Levocloperastine Fendizoate Oral Suspension – Huscol Suspension

Levocloperastine Fendizoate Oral Suspension – Advanced Antitussive + Antihistamine Formula for Upper Respiratory Relief

Huscol Suspension – Levocloperastine Fendizoate 35.4mg Eq. to Levocloperastine Hcl 20mg

Levocloperastine Fendizoate Oral Suspension is a next-generation, centrally acting antitussive designed to manage dry and persistent cough effectively. It modulates the cough reflex without the sedative or respiratory depressive effects seen with older agents. Its well-tolerated profile and sustained action ensure higher patient adherence, especially in individuals needing symptom control throughout the day and night.

Recommended by specialists:
✅General Physicians : For an uncomplicated dry cough needing non-sedative management
✅Pulmonologists: For chronic dry cough, post-viral or infection-related cough

Key benefits of Levocloperastine Fendizoate Oral Suspension – Huscol Suspension:

Powerful Cough Suppressant:
Acts directly on the central cough center to reduce the urge to cough, delivering fast and effective relief from dry, non-productive cough.

Daytime-Friendly, Non-Sedative Formula:
Unlike many traditional antitussives, Levocloperastine does not induce drowsiness, making it ideal for daytime use without impacting alertness.

Dual Mechanism of Action:
Not only suppresses the cough reflex but also exhibits mild anti-inflammatory effects, helping soothe airway irritation and improve overall respiratory comfort

Indications:
✅Dry, Irritative Cough
✅Cough Associated with Upper or Lower Respiratory Tract Infections
✅Post-Viral or Allergy-Induced Cough
✅Night-Time Cough Disturbs Sleep